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Background: The prospective, randomized SYNTAX trial was designed to compare PCI with TAXUS Express stents versus CABG for the treatment 
of 3VD and/or LM disease. The safety of drug-eluting stents has been questioned, particularly with regard to very late stent thrombosis (ST). ST risk 
factors include left main (LM) and multi-lesion/vessel stenting.
Methods: Patients with de novo LM and/or 3VD disease were randomized to either PCI or CABG if deemed suitable for either treatment option by 
consensus of a cardiac surgeon and an interventional cardiologist upon screening. Graft occlusion (GO) and ST were adjudicated by an independent 
clinical events committee, and classified as either angiographically confirmed or per protocol (ie, angiographically confirmed in the presence of 
acute coronary syndrome and/or Q-wave MI in the territory of ≥1 treated vessels within first 30 days (d)). The timing of events was classified as 
acute (≤1d post procedure), subacute (2-30d), late (31-365d), and very late (366-730d).
Results: A total of 1,800 patients were randomized to CABG (n=897) or PCI with TAXUS (n=903) (Table). The 2-year ARC ST (def/prob) KM rate was 
5.7%. Rates in the nested registries were also low (2 years: CABG registry, 3.5% and PCI registry 2.2%). ST/GO-related deaths at 1 year were 9/28 
(32%) PCI and 0/27 (0%) CABG; 2-year results will be presented.
Conclusion: In this traditionally CABG-treated population with LM and 3VD, both GO and ST were less frequent in the second year after treatment 
than the first. 
Table. Post-Procedure Graft Occlusion (CABG Arm) and Stent Thrombosis (TAXUS Arm) in the SYNTAX Trial Through 2 Years Follow-up
CABG
(N=897)
TAXUS
(N=903)
Angiographic Per-protocol Angiographic Per-protocol
< 1 day 0.3% (3/870) 0.3% (3/870) 0.2% (2/896) 0.2% (2/896)
2 - 30 days 0.3% (3/870) 0.3% (3/868) 2.0% (18/893) 2.0% (18/893)
31 - 365 days 2.5% (21/854) 1.4% (12/854) 1.0% (9/874) 0.9% (8/874)
366 - 730 days 1.9% (15/807) 0.2% (2/807) 0.6% (5/846) 0.6% (5/846)
Total 5.5% (42/763) 2.6% (20/760) 4.0% (33/830) 3.9% (32/830)
